awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40516279-76E3E861-AFE8-4B3D-8CBE-EF177885409F
Q40516279-76E3E861-AFE8-4B3D-8CBE-EF177885409F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40516279-76E3E861-AFE8-4B3D-8CBE-EF177885409F
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials.
P2860
Q40516279-76E3E861-AFE8-4B3D-8CBE-EF177885409F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40516279-76E3E861-AFE8-4B3D-8CBE-EF177885409F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d72b5c375bc68d42a6b3539028b605616a58e73
P2860
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res